Travere Therapeutics (TVTX) Net Margin (2014 - 2026)

Travere Therapeutics (TVTX) posted Net Margin of 0.39% for Q1 2026, up 94.41% on a QoQ basis from 7.03% in Q4 2025.

Travere Therapeutics (TVTX) Net Margin (2014 - 2026) Analysis & Trends

Travere Therapeutics' Net Margin history runs 13 years deep, the most recent figure standing at 0.39% for Q1 2026.

  • Quarterly Net Margin changed N/A year-over-year to 0.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 34.55% (down 3424.0% YoY) and the FY2025 annual result came in at 265.75%, up 26615.0% from the prior year.
  • Net Margin was 0.39% for Q1 2026 at Travere Therapeutics, up from 7.03% in the prior quarter.
  • Across five years, Net Margin topped out at 646.92% in Q3 2023 and bottomed at 7.03% in Q4 2025.
  • A 5-year average of 64.78% and a median of 12.32% in 2022 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2023 — Net Margin soared 59561 bps — and 2024, when it plunged 64702 bps.
  • Travere Therapeutics' Net Margin stood at 67.53% in 2022, then slumped by 105 bps to 3.5% in 2023, then jumped by 99 bps to 0.02% in 2024, then sank by 34933 bps to 7.03% in 2025, then surged by 94 bps to 0.39% in 2026.
  • Business Quant data shows TVTX's Net Margin at 0.39% in Q1 2026, 7.03% in Q4 2025, and 0.02% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 15.02%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 34.53%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 20.17%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 30.33%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Travere Therapeutics 5.21 Bn 5.21 Bn 125.25 Mn -0.39%

Historic Data

Download Data
DateValue
Mar 31, 2026 -0.39%
Dec 31, 2025 -7.03%
Dec 31, 2024 -0.02%
Sep 30, 2024 -0.09%
Jun 30, 2024 -1.40%
Mar 31, 2024 -0.25%
Dec 31, 2023 -3.50%
Sep 30, 2023 646.92%
Jun 30, 2023 50.63%
Mar 31, 2023 33.13%
Dec 31, 2022 67.53%
Sep 30, 2022 51.32%
Jun 30, 2022 45.37%
Mar 31, 2022 24.67%
Dec 31, 2021 56.10%
Sep 30, 2021 -52.24%
Jun 30, 2021 -71.43%
Mar 31, 2021 -113.63%
Dec 31, 2020 -238.55%
Sep 30, 2020 -44.09%